You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

 

718 Results
Statistical Reports
Dec 1969
Regimen
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Sacituzumab Govitecan - Unresectable Locally Advanced or Metastatic Triple Negative Breast Cancer
New Drug Funding Program
    Sacituzumab Govitecan - HR-positive HER2-negative Unresectable Locally Advanced or Metastatic Breast Cancer
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
sacituzumab govitecan
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jul 2025
Document
New
Jul 2025
Drug
Other Name(s): Trodelvy®
Quick Link(s): Drug Monograph, Patient Info Sheet
Jul 2025
The Provincial Drug Reimbursement Programs (PDRP) administers funding programs for cancer drugs and services. These programs help patients access...
Les programmes provinciaux de remboursement des médicaments (PPRM) permettent de financer les médicaments contre le cancer et les services connexes....
Drug
Other Name(s): Neulasta®, Lapelga®, Fulphila™; Ziextenzo®; Nyvepria™, Niopeg®, Pexegra™
Quick Link(s): Drug Monograph, Patient Info Sheet
Dec 1969
Drug
Other Name(s): Caelyx®
Quick Link(s): Drug Monograph, Patient Info Sheet
Mar 2025
Guidelines and Advice
Status: Current
Dec 1969
Drug
Other Name(s): Keytruda®
Quick Link(s): Drug Monograph, Patient Info Sheet
Updated
Sep 2025

Pages